Akeega Niraparib Abiraterone BRCA Mutated Prostate Cancer 2026
Author: Critical Kare PharmaUrologic Precision Oncology Desk
On November 12, 2026, genitourinary oncology congresses underscored the therapeutic success of Akeega® (Niraparib 50 mg / Abiraterone acetate 500 mg dual fixed-dose film-coated tablets) by Janssen/Johnson & Johnson in BRCA1/2-mutated metastatic castration-resistant prostate cancer (mCRPC).
By uniting potent poly (ADP-ribose) polymerase (PARP) catalytic inhibition with androgen biosynthesis blockade into a single daily oral tablet, Akeega establishes synthetic lethality, prolonging radiographic progression-free survival (rPFS) in one of the most aggressive prostate cancer molecular subsets.
Through Critical Kare Pharma, certified genuine packs of Akeega Niraparib Abiraterone Tablets are distributed directly to oncology clinics and named patients worldwide.
The MAGNITUDE Phase 3 Trial Benchmarks
- rPFS Improvement: In patients with BRCA1/2 gene alterations, Akeega plus prednisone demonstrated a statistically significant 47% reduction in the risk of radiographic progression or death compared to abiraterone acetate plus prednisone alone (HR 0.53).
- Time to Symptomatic Progression (TSP): Delayed time to cytotoxic chemotherapy initiation and substantially prolonged time to pain progression.
- Overall Survival Signal: Strong, consistent trend toward extended median overall survival in BRCA-positive cohorts.
Dual Synthetic Lethality Mechanism
Androgen receptor (AR) signaling promotes transcription of homologous recombination repair (HRR) genes in prostate cancer cells. Abiraterone's CYP17 inhibition deprives tumor cells of androgenic ligands, inducing a state of "functional BRCAness." Concurrently, niraparib traps PARP-1 and PARP-2 on damaged single-strand DNA breaks, causing catastrophic double-strand breaks that BRCA-deficient tumors cannot repair, driving selective apoptosis.
Administration & Clinical Surveillance
Standard dosing is two tablets (100 mg niraparib / 1000 mg abiraterone acetate) taken orally once daily on an empty stomach with prednisone 10 mg daily. Monitoring of complete blood counts, hepatic transaminases, and blood pressure is required. Critical Kare Pharma manages international import licenses and rapid delivery across Asia, Europe, Latin America, and the Middle East.
